Race Oncology in Melbourne, Victoria, Australia | Pharmaceutical company

Race Oncology

Locality: Melbourne, Victoria, Australia

Phone: +61 3 9098 8750

Address: L40, 140 William Street 3000 Melbourne, VIC, Australia

Website: http://www.raceoncology.com/

Likes: 211

Add/Update information

Reviews

Tags

• Medical and health
• Medical research centre
• Pharmaceutical company

15.05.2022 Race Oncology has appointed the internationally renowned haematologist Didier Blaise to its Clinical Advisory Board. https://loom.ly/8qsnzTc

07.05.2022 Thanks for the article SmallCaps.

28.04.2022 Race Oncology has received firm commitments for A$1.8 million to advance its 5-Path clinical strategy for Bisantrene and also welcomes the appointment of Dr John Cullity as Non-Executive Chairman.

13.04.2022 Race has appointed highly experienced oncology clinical trials specialist Dr Marinella Messina as its Australian Clinical Program Director. https://loom.ly/0do7Sf0

07.04.2022 Race Oncology begins to roll out its 5-path clinical strategy for cancer drug Bisantrene.

24.03.2022 Leading haematologist and stem cell transplant expert Professor Borje Andersson appointed Director of Race Oncology. Read more here: https://www.raceoncology.com/professor-borje-andersson-app/

20.03.2022 Race chief execs discuss the value of commercialising Bisantrene on Stockhead's The Health Kick Podcast.

17.03.2022 World-recognised leukaemia and stem cell transplantation researcher Prof Borje Andersson will chair Race's Clinical Advisory Board.

13.03.2022 Race Oncology has revealed a new 5 Path clinical development strategy for cancer drug, Bisantrene. The new strategy builds on the value embedded in the drug from its use in more than 40 prior human trials across a range of cancers.

25.02.2022 Stockhead: RAC has nearly doubled since a major biotech entrepreneur backed the company.

15.02.2022 Thanks Small Caps for the coverage of our new Chief Scientific Officer Dr Daniel Tillett.

13.02.2022 Race Oncology @RaceOncology 1m Race Oncology is delighted to announce the appointment of Dr Daniel Tillet as Chief Financial Officer. #cancer #cancerdrug #biotech

02.02.2022 BioSpace: Race Oncology strengthens board with prominent biotech investor Dr Daniel Tillett. https://loom.ly/4Ao2b5w